Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, December 1, 2009, 8:49PM ET - U.S. Markets Closed. Dow Up 1.23% Nasdaq Up 1.46%
Genomic Health Inc. (GHDX)At 4:00PM ET: 19.41  Up 0.40 (2.10%)  
MORE ON GHDX
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Genomic Health Inc.
301 Penobscot Drive
Redwood City, CA 94063
United States - Map
Phone: 650-556-9300
Fax: 650-556-1132
Web Site: http://www.genomichealth.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Laboratories & Research
Full Time Employees:387

BUSINESS SUMMARY 
Genomic Health, Inc. operates as a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. The company launched the Oncotype DX breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit, as well as recurrence in early-stage breast cancer in 2004. In addition to its adopted Oncotype DX breast cancer test, Genomic Health is preparing to launch its Oncotype DX colon cancer test in early 2010. The company was founded in 2000 and is based in Redwood City, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Genomic Health Inc.


    CORPORATE GOVERNANCE 
    Genomic Health Inc.'s Corporate Governance Quotient (CGQ®) as of 6-Nov-09 is better than 51% of Russell 3000 companies and 55.4% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Dr. Randy W. Scott Ph.D., 51
    Co-Founder and Exec. Chairman
    N/A N/A
    Ms. Kimberly Popovits , 50
    Chief Exec. Officer, Pres
    $ 415.00K $ 0
    Mr. G. Bradley Cole , 53
    Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer and Sec.
    $ 360.00K $ 406.00K
    Dr. Steven Shak M.D., 58
    Chief Medical Officer
    $ 382.00K $ 0
    Dr. Joffre B. Baker Ph.D., 61
    Chief Scientific Officer and Chairman of Nominating & Corp. Governance Committee
    $ 372.00K $ 0
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis